Verona Pharma American Depositary Share SG&A Expenses 2017-2024 | VRNA

Verona Pharma American Depositary Share sg&a expenses for the twelve months ending December 31, 2024 were $0.150B, a 197.4% increase year-over-year.

  • Verona Pharma American Depositary Share annual sg&a expenses for 2024 were $0.15B, a 197.4% increase from 2023.
  • Verona Pharma American Depositary Share annual sg&a expenses for 2023 were $0.05B, a 89.45% increase from 2022.
  • Verona Pharma American Depositary Share annual sg&a expenses for 2022 were $0.027B, a 21.61% decline from 2021.

Verona Pharma American Depositary Share SG&A Expenses 2017-2024 | VRNA

  • Verona Pharma American Depositary Share annual sg&a expenses for 2024 were $0.15B, a 197.4% increase from 2023.
  • Verona Pharma American Depositary Share annual sg&a expenses for 2023 were $0.05B, a 89.45% increase from 2022.
  • Verona Pharma American Depositary Share annual sg&a expenses for 2022 were $0.027B, a 21.61% decline from 2021.